Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Department of Pharmacology, Penn State University College of Medicine, Hershey, Pennsylvania.
Proteins. 2019 Oct;87(10):878-884. doi: 10.1002/prot.25751. Epub 2019 Jun 12.
The G protein-coupled μ-opioid receptor (μ-OR) mediates the majority of analgesia effects for morphine and other pain relievers. Despite extensive studies of its structure and activation mechanisms, the inherently low maturation efficiency of μ-OR represents a major hurdle to understanding its function. Here we computationally designed μ-OR mutants with altered stability to probe the relationship between cell-surface targeting, signal transduction, and agonist efficacy. The stabilizing mutation T315Y enhanced μ-OR trafficking to the plasma membrane and significantly promoted the morphine-mediated inhibition of downstream signaling. In contrast, the destabilizing mutation R165Y led to intracellular retention of μ-OR and reduced the response to morphine stimulation. These findings suggest that μ-OR stability is an important factor in regulating receptor signaling and provide a viable avenue to improve the efficacy of analgesics.
G 蛋白偶联 μ 阿片受体(μ-OR)介导了吗啡和其他止痛药的大部分镇痛作用。尽管对其结构和激活机制进行了广泛的研究,但 μ-OR 的固有低成熟效率仍是理解其功能的主要障碍。在这里,我们通过计算设计了具有改变稳定性的 μ-OR 突变体,以探究细胞表面靶向、信号转导和激动剂效能之间的关系。稳定化突变 T315Y 增强了 μ-OR 向质膜的转运,并显著促进了吗啡介导的下游信号抑制。相比之下,去稳定化突变 R165Y 导致 μ-OR 在细胞内滞留,并减少了对吗啡刺激的反应。这些发现表明 μ-OR 的稳定性是调节受体信号的一个重要因素,并为提高镇痛药的疗效提供了可行的途径。